Hangzhou Tianyuan Pet Products Future Growth
Future criteria checks 4/6
Hangzhou Tianyuan Pet Products is forecast to grow earnings and revenue by 26.9% and 17.9% per annum respectively while EPS is expected to grow by 27.3% per annum.
Key information
26.9%
Earnings growth rate
27.3%
EPS growth rate
| Household Products earnings growth | 41.6% |
| Revenue growth rate | 17.9% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 28 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 2,927 | 133 | 10 | 68 | 2 |
| 12/31/2024 | 2,641 | 132 | 83 | 16 | 1 |
| 3/31/2024 | 2,113 | 77 | 350 | 400 | N/A |
| 12/31/2023 | 2,037 | 77 | -40 | 16 | N/A |
| 9/30/2023 | 1,906 | 86 | -229 | -177 | N/A |
| 3/31/2023 | 1,890 | 123 | -577 | -547 | N/A |
| 1/1/2023 | 1,887 | 129 | -190 | -172 | N/A |
| 9/30/2022 | 2,030 | 121 | -55 | -32 | N/A |
| 1/1/2022 | 1,854 | 107 | -26 | 24 | N/A |
| 12/31/2020 | 1,450 | 114 | -122 | 50 | N/A |
| 12/31/2019 | 1,049 | 87 | -9 | 66 | N/A |
| 12/31/2016 | 584 | 45 | N/A | 37 | N/A |
| 9/30/2016 | 557 | 41 | N/A | 19 | N/A |
| 6/30/2016 | 530 | 36 | N/A | 2 | N/A |
| 3/31/2016 | 527 | 34 | N/A | 12 | N/A |
| 12/31/2015 | 524 | 32 | N/A | 22 | N/A |
| 12/31/2014 | 490 | 30 | N/A | 35 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 301335's forecast earnings growth (26.9% per year) is above the savings rate (2.9%).
Earnings vs Market: 301335's earnings (26.9% per year) are forecast to grow faster than the CN market (24.3% per year).
High Growth Earnings: 301335's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 301335's revenue (17.9% per year) is forecast to grow faster than the CN market (14.6% per year).
High Growth Revenue: 301335's revenue (17.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 301335's Return on Equity is forecast to be high in 3 years time